Brief: Point72 Asset Management LP Reports 7.3% Passive Stake In Relmada Therapeutics Inc As Of October 13 - SEC Filing
17/10/2022 11:38
Oct 17 (Reuters) - Relmada Therapeutics Inc RLMD.O :
* POINT72 ASSET MANAGEMENT LP REPORTS 7.3% PASSIVE STAKE IN
RELMADA THERAPEUTICS INC AS OF OCTOBER 13 - SEC FILING
Further company coverage: RLMD.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Relmada Therapeutics
See all newsRelmada Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Relmada Therapeutics Q2 EPS USD -0.11
Relmada Therapeutics Inc expected to post a loss of 20 cents a share - Earnings Preview
Brief: Relmada Therapeutics Appoints Uro-Oncology Leader Bipin Dalmia As Chief Business Officer
Brief: Relmada Therapeutics - Increases Authorized Common Stock To 200 Million Shares From 150 Million